Healthcare & Life Sciences

Apoptogenth Ltd

United Kingdom
Sign in to unlock

About

Apoptogenth Ltd is a University of Leeds spin-out developing a haematopoietic stem cell gene therapy that uses tumour-infiltrating myeloid cells to deliver apoptosis-inducing genes directly to brain metastases, targeting metastatic brain tumors resistant to conventional therapies.

Explore Apoptogenth Ltd's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing